PPARγ与TGFβ在慢性缺血性肾脏病的研究进展(2)
[3]Kidney Disease Outcomes Quality Initiative(K/DOQI): K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease[J]. Am J Kidney Dis, 2004,43(5 S 1):1–290.[4]de Silva R, Nikitin N P, Bhandari S, et al . Atherosclerotic Renovascular Disease in Chronic Heart Failure: Should We Intervene?[J]. Eur Heart J,2005,26(16):1596-1605.
[5]Wynn TA.Cellular and molecular mechanisms of fibrosis.J Pathol ......
您现在查看是摘要页,全文长 2491 字符。